New Zealanders like to think of themselves as high users of the latest technology. Does this extend to digital imagery in the workplace? Curators at the Auckland Art Gallery Toi o Tāmaki were surveyed regarding digital image sources, their use and the problems and opportunities they presented. They were found to be keen, adept users, satisfied with their technical and retrieval capabilities, and aware of issues relating to copyright and image storage. Happy with thumbnails in many instances, they employed the skills of the Gallery’s professional photographers when higher quality images were required. Looking at the move from analogue to digital, slide use was found to be negligible but reproductions in books and journals were still a favoured source. Disadvantages were downplayed and the positive impact of digital imagery was stressed.

No abstract

In recent years we have noticed a substantial increase in interest in our archive collections at the E H McCormick Research Library at Auckland Art Gallery Toi o Tāmaki. With circulation figures for print publications generally reported to be on a downward trend for libraries, unique material is being eagerly sought out.Who are our new audiences and how do they engage with archives in varying ways? What specific approaches have contributed to achieving this positive shift? Including observations from other research librarians and archivists, this article provides a view of art archive use and users, as well as the mechanisms that are proving successful. Our aim is to increase the visibility of our special collections to facilitate the unlocking of their powerful potential for the understanding and, sometimes, making of art.

BACKGROUND Primary care plays a key role in management of type 2 diabetes. SGLT2 inhibitors have been demonstrated to also reduce hospitalisation and cardiac and renal complications. Tools that optimise management, including appropriate prescribing, are a priority for treating chronic diseases. Future Health Today is software which facilitates clinical decision support and quality improvement activities. OBJECTIVE The study aims to explore the barriers and enablers to implementation of an SGLT2 inhibitor module within Future Health Today software. METHODS Clinic staff were recruited to participate in interviews on their experience in their use of a tool to improve SGLT2 inhibitor prescribing. Thematic analysis was guided by Clinical Performance Feedback Intervention Theory. RESULTS Sixteen interviews were completed. The enablers included workflow alignment, clinical appropriateness, and active delivery of the module. Key barriers to use were competing priorities, staff engagement and knowledge of the clinical topic. CONCLUSIONS There is a recognised benefit for the use of a clinical decision support tool to support type 2 diabetes management, but barriers were identified that impeded the usability and actionability of the module. Successful and effective implementation of this tool could support the optimisation of patient management of type 2 diabetes in primary care.